Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Cureus|July 3, 2026
Refractory and/or Resistant Herpes Simplex Virus Mucocutaneous Infections in Adult Transplantation and Cellular Therapy Patients: A Single-Center ExperienceJoseph I Berger, Anthony D Anderson, Octavio V Martinez, et al.
Ophthalmology Science|November 28, 2024
Systemic Treatment with the Janus Kinase Inhibitor Baricitinib in Ocular Chronic Graft-versus-Host DiseaseTaylor McManus, Noa G Holtzman, Aaron Zhao, et al.
Blood Advances|June 5, 2024
Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapyRick Y Lin, Anthony D Anderson, Yoichiro Natori, et al.
Bone Marrow Transplantation|February 2, 2021
Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host diseaseClaire L Ruben, Filip Pirsl, Seth M Steinberg, et al.
Blood|May 7, 2025
Phase 1/2 Study of High-Dose Palifermin for GVHD Prophylaxis in Patients Undergoing HLA-Matched Unrelated Donor HCTEduard Schulz, Lauren M Curtis, Noa G Holtzman, et al.
Neuro-Oncology|August 5, 2020
Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomesNoa G Holtzman, Hao Xie, Soren Bentzen, et al.
Biology|April 3, 2021
<i>FLT3</i>-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk StratificationAndrew Y Li, Sarah M Kashanian, Bryan C Hambley, et al.
Mycopathologia|February 5, 2026
Clinical Characteristics and Outcomes of Invasive Aspergillosis in Patients with Hematological Malignancies and Transplantation and Cellular Therapies in the Contemporary EraChristopher M Lopez, Jose F Suarez, Maria A Mendoza, et al.
Blood Advances|April 26, 2024
High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease preventionNoa G Holtzman, Lauren M Curtis, Rachel B Salit, et al.
Blood Advances|May 27, 2026
Baricitinib for refractory chronic graft-versus-host-disease: Results of a phase 1/2 studyNoa G Holtzman, Annie Im, Lauren M Curtis, et al.
Pageof 4